Study of Patients Being Treated With Anti-obesity Medication

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Dec 2027 → Mar 2028
See other at-risk trials from Texas Tech University

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment closed, study ongoing Show 4 more changesShow less
    • Primary and study completion pushed from Dec 2027 to Mar 2028
    • Site details revised
    • Eligibility criteria expanded, about 5 words
    • Study description expanded, about 3 words
  2. Notable Primary and study completion dates: Feb 2027 to Dec 2027v3
  3. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 2025 to Jan 31, 2025
    • Collaborator revised
    • Study title shortened, about 1 word
  4. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3,888 trials monitored
See 157 trials at risk
The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.
Trial Details
NCT Number NCT06790160
Lead Sponsor Texas Tech University
Collaborators: Vineyard Health Inc.
Conditions
(from sponsor)
Obesity and Overweight
Related terms Motor Activity, Obesity, Overweight
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov